[Chine] Covid-19 vaccines made by China’s Sinopharm, CanSino release efficacy data
– Wuhan unit of state-owned Sinopharm, whose first vaccine was approved for general use in December, says second product has an efficacy rate of 72.5 per cent
– CanSino puts efficacy rate of its vaccine at 65 per cent, but says it is 90 per cent effective at preventing severe symptoms